A natural lead-in approach to response-adaptive allocation for continuous outcomes

Area of Science:

• Biostatistics
• Clinical Trial Design
• Bayesian Statistics

Background:

• Response-adaptive (RA) designs dynamically allocate subjects to better-performing treatments.
• Early-stage adaptation in RA designs can be hindered by unstable estimators and high variability.
• Bayesian methods, particularly decreasingly informative priors (DIP), offer a solution to mitigate these early-stage challenges.

Purpose of the Study:

• To extend the DIP approach for RA designs to continuous outcomes.
• To investigate a novel functionalization of the prior effective sample size within the DIP framework.
• To compare the performance of this new DIP approach against existing methods and traditional designs.

Main Methods:

• Developed a DIP approach for RA designs with continuous outcomes, focusing on the normal conjugate family.
• Functionalized the prior effective sample size to match the unobserved sample size.
• Compared the effective sample size DIP approach with other DIP formulations and allocation equations.
• Utilized simulated clinical trials to evaluate performance against Frequentist RA, Bayesian RA, and balanced designs.

Main Results:

• The effective sample size DIP approach demonstrated improved treatment allocation and maintained higher power.
• This method resulted in lower variability compared to traditional RA designs.
• The natural lead-in approaches, when utilizing DIPs, showed robust performance in simulations.

Conclusions:

• The extended DIP approach effectively addresses challenges in early-stage adaptation for RA designs with continuous outcomes.
• This Bayesian methodology offers a powerful tool for optimizing clinical trial efficiency and treatment effectiveness.
• Simulations confirm the superiority of DIP-enhanced RA designs in terms of power and reduced variability.